DXP ENTERPRISES INC (DXPE)·Q3 2025 Earnings Summary
Executive Summary
- Mixed print vs consensus: revenue beat while EPS missed; Q3 sales were $513.7M (+8.6% Y/Y, +3.0% Q/Q) with Adjusted EBITDA of $56.5M (11.0% margin), but GAAP diluted EPS of $1.31 and Adjusted EPS of $1.34 came in below S&P EPS consensus of $1.565; revenue beat $498.8M consensus, EBITDA was roughly in line* .
- Strength in Service Centers and IPS offset SES softness; gross margin held 31.4% (+50 bps Y/Y), with Service Centers up 10.5% Y/Y to $350.2M and IPS up 11.9% Y/Y to $100.6M; SES declined 5.0% Y/Y to $63.0M .
- Non-operational SG&A pressures (insurance renewal timing, higher health claims, acquisition costs) weighed on EPS; management reiterated confidence in sustainable ~11% Adjusted EBITDA margins despite seasonal Q4 fewer billing days .
- Strategy execution and M&A momentum continue, with two water/wastewater acquisitions post quarter-end (APSCO; Triangle Pump) bolstering the IPS water platform heading into 2026 .
What Went Well and What Went Wrong
What Went Well
- Record quarterly sales and resilient gross margin: revenue hit a new high at $513.7M; consolidated gross margin was 31.39% (+50 bps Y/Y), supported by mix and accretive acquisitions .
- Segment outperformance in Service Centers and IPS: Service Centers +10.5% Y/Y to $350.2M (14.7% OI margin), IPS +11.9% Y/Y to $100.6M (18.3% OI margin); both also grew sequentially (SC +3.1%, IPS +7.5%) .
- Positive strategic tone and pipeline: “We continue to set new high watermarks… Adjusted EBITDA was $56.5 million in the quarter” (CEO) and “We have closed two acquisitions during the fourth quarter thus far with more to come” (CFO) .
What Went Wrong
- EPS miss despite revenue strength: GAAP diluted EPS $1.31 and Adjusted EPS $1.34 vs S&P EPS consensus $1.565; non-operational SG&A factors elevated costs (insurance renewal timing, health claims, M&A fees) pressuring earnings* .
- SES softness and seasonality: Supply Chain Services down 5% Y/Y and -3.7% Q/Q due to pullbacks at oil & gas and chemical sites, and expected Q4 seasonality with fewer billing days .
- Early signs of moderation in IPS energy backlog: Q3 energy-related average backlog declined 3.3% (first decline in 10 quarters), though still above long-term averages; management will watch Q4/Q1 backlog trajectory .
Financial Results
Consolidated performance vs prior periods
Notes: Gross margin Q/Q/Y/Y values for Q3 2025 per management 31.39% (+50 bps Y/Y) .
Segment breakdown
Sequential growth (management): Service Centers +3.1%, IPS +7.5%, SES -3.7% .
KPIs and balance sheet/cash flow
Guidance Changes
No quantitative revenue/EPS guidance was provided in the press release or call .
Earnings Call Themes & Trends
Management Commentary
- CEO: “We continue to set new high watermarks… Adjusted EBITDA was $56.5 million in the quarter… sales were $350.2M (SC), $100.6M (IPS), and $63.0M (SES). Overall, we are very pleased with our performance” .
- CFO: “We feel plenty comfortable with 11% [Adjusted EBITDA margin]… trending now at a sustainable 11%+… Q4 is lighter from fewer days but we still expect mix to get us to that 11%” .
- CFO on SG&A: Elevated by mid-year insurance renewal timing, higher self-insured health claims, and higher professional fees tied to acquisitions; impact likely to persist near term given active pipeline .
- CEO closing: “Record sales… Gross profit margins are… holding. Expenses were a little higher than expected, but… for the right reasons… Free cash flow improved to $28.2M… We continue to hit adjusted EBITDA margins of 11%” .
Q&A Highlights
- Monthly cadence and Q4 start: July $7.26M/day, August $7.95M/day, September $8.9M/day; October at $7.59M/day reflecting typical Q4 seasonality .
- EBITDA margin outlook: Sustainable ~11%+ near term; holiday-related fewer billing days in Q4 but mix expected to keep margins around target .
- Corporate SG&A drivers: Insurance renewal timing/premium increases, self-insured health claims, acquisition-related professional fees drove Q3 SG&A above run-rate .
- Data centers: Limited contribution today; pursuing opportunities across pumps, water, filtration; diversified national efforts underway .
Estimates Context
Notes: Consensus from S&P Global; Primary EPS reflects S&P “Primary EPS” (adjusted). Company-reported Adjusted Diluted EPS used for “Actual” EPS comparisons; company-reported EBITDA used for “Actual” EBITDA comparisons. Values retrieved from S&P Global.*
Implications: The Q3 revenue beat alongside an EPS miss suggests higher-than-modeled SG&A and/or mix headwinds (insurance/claims/M&A costs) suppressed EPS; estimates may shift lower on EPS/EBITDA margin while revenue trajectories likely move higher given September strength and M&A adds .
Key Takeaways for Investors
- Revenue momentum intact; September sales/day acceleration and record Service Centers/IPS output, plus post-quarter M&A, support sustained top-line strength into 2026 .
- Margin construct resilient at ~11% Adjusted EBITDA; management reiterated sustainability despite Q4 seasonality and SG&A timing effects .
- Mixed print vs Street (rev beat, EPS miss) likely refocuses debate on SG&A normalization and acquisition cadence/integration benefits over coming quarters .
- IPS water remains a structural tailwind; backlog and platform build-out reduce cyclicality vs legacy energy exposure, though energy backlog bears watching after a modest decline .
- SES softness appears transitory/seasonal; management expects a stronger 2026 as new customer implementations scale and billing days normalize .
- Balance sheet/liquidity provide dry powder (cash $123.8M; undrawn ABL; availability $153.4M; liquidity $277.3M) to continue tuck-ins while maintaining ~2.3x secured leverage .
- Trading setup: near-term catalysts include Q4 seasonality outcomes vs 11% margin target and incremental water-platform M&A; watch SG&A normalization and backlog trajectory to gauge EPS recovery .
Appendix: Additional Detail
- LTM covenant EBITDA $225.1M; total debt $644M; secured leverage 2.31x; liquidity $277.3M including $123.8M cash .
- Free cash flow improved to $28.1M in Q3 on stronger operating cash flow and moderating CapEx .
- Organic sales per business day rose to $7.739M (vs $6.944M in Q3’24), reflecting core demand strength .
Citations: Press release and 8‑K (financials): . Earnings call transcript: . Prior quarters’ releases: . Acquisitions (post-Q3): .
S&P Global disclaimer: Consensus estimate values and “Primary EPS Consensus Mean,” “Revenue Consensus Mean,” and “EBITDA Consensus Mean” are from S&P Global and marked with an asterisk (*).